FI56388C - Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 1-n-ny-amino-alfa-hydroxibutyryl-substituerad kanamycin(a eller b)-foerening - Google Patents

Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 1-n-ny-amino-alfa-hydroxibutyryl-substituerad kanamycin(a eller b)-foerening Download PDF

Info

Publication number
FI56388C
FI56388C FI1988/72A FI198872A FI56388C FI 56388 C FI56388 C FI 56388C FI 1988/72 A FI1988/72 A FI 1988/72A FI 198872 A FI198872 A FI 198872A FI 56388 C FI56388 C FI 56388C
Authority
FI
Finland
Prior art keywords
kanamycin
amino
formula
compound
hydroxybutyryl
Prior art date
Application number
FI1988/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI56388B (fi
Inventor
Hiroshi Kawaguchi
Takayuki Naito
Susumu Nakagawa
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of FI56388B publication Critical patent/FI56388B/fi
Publication of FI56388C publication Critical patent/FI56388C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI1988/72A 1971-07-13 1972-07-12 Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 1-n-ny-amino-alfa-hydroxibutyryl-substituerad kanamycin(a eller b)-foerening FI56388C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16231571A 1971-07-13 1971-07-13
US16231571 1971-07-13
US22137872A 1972-01-27 1972-01-27
US22137872 1972-01-27

Publications (2)

Publication Number Publication Date
FI56388B FI56388B (fi) 1979-09-28
FI56388C true FI56388C (fi) 1980-01-10

Family

ID=26858650

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1988/72A FI56388C (fi) 1971-07-13 1972-07-12 Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 1-n-ny-amino-alfa-hydroxibutyryl-substituerad kanamycin(a eller b)-foerening

Country Status (24)

Country Link
JP (1) JPS5239024B2 (nl)
AR (1) AR201265A1 (nl)
AU (1) AU462657B2 (nl)
BE (1) BE786201A (nl)
CA (1) CA966831A (nl)
CH (1) CH577502A5 (nl)
CY (1) CY953A (nl)
DD (1) DD98927A5 (nl)
DK (1) DK136251B (nl)
EG (1) EG10889A (nl)
ES (1) ES404747A1 (nl)
FI (1) FI56388C (nl)
FR (1) FR2145649B1 (nl)
GB (1) GB1401221A (nl)
HK (1) HK33678A (nl)
IE (1) IE36539B1 (nl)
IL (1) IL39872A (nl)
KE (1) KE2850A (nl)
MY (1) MY7800312A (nl)
NL (1) NL160271C (nl)
PH (2) PH9589A (nl)
SE (1) SE392470B (nl)
SG (1) SG20778G (nl)
YU (1) YU36533B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154536A (en) * 1974-11-06 1976-05-13 Banyu Pharma Co Ltd 6**nn * benjiruokishikaruboniru * kanamaishinjudotaino seiho
FR2318648A1 (fr) * 1975-07-23 1977-02-18 Roussel Uclaf Nouveau derive de la desoxystreptamine et des sels, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DE2234315B2 (de) 1977-03-17
NL7209617A (nl) 1973-01-16
BE786201A (fr) 1973-01-12
AR201265A1 (es) 1975-02-28
DD98927A5 (nl) 1973-07-12
MY7800312A (en) 1978-12-31
AU4434372A (en) 1974-01-10
JPS4834856A (nl) 1973-05-22
IE36539L (en) 1973-01-13
NL160271C (nl) 1979-10-15
SG20778G (en) 1987-04-03
IL39872A (en) 1974-10-22
FI56388B (fi) 1979-09-28
DE2234315A1 (de) 1973-02-08
SE392470B (sv) 1977-03-28
GB1401221A (en) 1975-07-16
FR2145649B1 (nl) 1976-04-16
IL39872A0 (en) 1972-09-28
DK136251B (da) 1977-09-12
CA966831A (en) 1975-04-29
HK33678A (en) 1978-07-07
KE2850A (en) 1978-08-04
CH577502A5 (nl) 1976-07-15
PH9589A (en) 1976-01-19
ES404747A1 (es) 1976-04-16
CY953A (en) 1978-12-22
YU36533B (en) 1984-02-29
AU462657B2 (en) 1975-07-03
EG10889A (en) 1976-10-31
FR2145649A1 (nl) 1973-02-23
IE36539B1 (en) 1976-11-24
NL160271B (nl) 1979-05-15
DK136251C (nl) 1978-02-13
YU181872A (en) 1982-02-25
PH11440A (en) 1978-02-01
JPS5239024B2 (nl) 1977-10-03

Similar Documents

Publication Publication Date Title
US3781268A (en) Antibiotic derivatives of kanamycin
US4091032A (en) 4-N-acylfortimicin B derivatives and the chemical conversion of fortimicin B to fortimicin A
US3897412A (en) Paromomycin antibiotic derivatives
US3808198A (en) Lividomycin b derivatives
US4055715A (en) Method of producing 1-N-[L-(-)-α-hydroxy-γ-aminobutyryl]XK-62-2
US4170642A (en) Derivatives of kanamycin A
US3872079A (en) Semisynthetic derivatives of tobramycin
CA1081692A (en) Method for production of kanamycin c and its derivatives
US3896106A (en) Antibiotic derivatives
DK149775B (da) Analogifremgangsmaade til fremstilling af 6'-n-methylkanamycin a- og b-derivater
US4104372A (en) 1-N-(α-hydroxy-ω-aminoalkanoyl) derivatives of 3'-deoxykanamycin A and the production thereof
FI56388C (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 1-n-ny-amino-alfa-hydroxibutyryl-substituerad kanamycin(a eller b)-foerening
US3939143A (en) 1-N-isoserylkanamycins and the production thereof
US4547492A (en) 1-N-(ω-Amino-α-hydroxyalkanoyl-2',3'-dideoxykanamycin A and pharmaceutical composition containing same
US3796698A (en) Antibiotic derivatives of gentamicin c2
HU188079B (en) Process for producing 3-o-dimethyl derivatives of istamycin b
CA1046513A (en) Antibiotic derivatives
US4140849A (en) Kanamycin C derivatives
US4362866A (en) Aprosamine derivatives
US4298727A (en) 3',4'-Dideoxykanamycin A and 1-N-(S)-α-hydroxy-ω-aminoalkanoyl) derivatives thereof
US4479943A (en) 3-Demethoxyistamycin B, the 2"-N-formimidoyl derivative thereof and pharmaceutical composition containing same
EP0546179B1 (en) 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof
US4147861A (en) 1N-(α-Hydroxy-ω-aminoalkanoyl)-6'N-methyl-3',4'-dideoxykanamycin B and the production thereof
EP0094625B1 (en) Novel aminoglycosides and process for production thereof
EP0185323B1 (en) 2',3'-dideoxy-2'-fluorokanamycin a and 1-n-(alpha-hydroxy-omega-aminoalkanoyl) derivatives thereof